GPs will be prescribing Mounjaro to a select few people as the rollout begins, but others may need to avoid the jabs ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

A new trial has found that a weight loss drug taken monthly helps people to lose 20 percent of their body weight. Other weight loss medications such as Ozempic, Wegovy and Mounjaro have become popular ...

Around a fifth of users report not losing the expected amounts of weight on Mounjaro, and doctors have some answers ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and ...